SCHD vs. VYM vs. DGRO: I Ran the Numbers for 2026.

SCHD is up roughly 12% year-to-date and yields 3.39%, with a portfolio weighting of ~21% energy, 17% consumer defensive and 16% healthcare and only ~9% tech exposure. The article argues SCHD offers a better mix of headline yield and dividend growth versus peers (VYM yield 2.35%; DGRO 3yr dividend growth ~7.49%, 5yr ~7.11%, 10yr ~8.59%; SCHD 3yr ~7.06%, 5yr ~9.15%, 10yr ~10.61%). Author expects capital rotation into defensive/dividend stocks to sustain SCHD’s leadership among dividend ETFs, while cautioning the recent run may not persist at the same pace.

Analysis

Recent fund flows and price action look less like a pure preference for higher current yield and more like a liquidity-driven re-rate away from high-volatility AI-exposed growth into large-cap, cash-generative dividend payers. Because SCHD’s index construction concentrates in established payers in energy/healthcare/consumer staples, it behaves like a defensive core with embedded cyclicality — it will capture commodity-driven cash flow moves while still trading on dividend valuation multiples rather than secular growth momentum. Expect the current leadership to be amplified by ETF rebalancing mechanics: passive funds that lag momentum will be forced buyers of dividend-weighted names on any month of underperformance in tech, producing short-term convexity in SCHD flows.

Second-order winners include high-quality energy dividend payers and health-care dividend aristocrats that sit in SCHD’s weighting; these issuers will see lower cost-of-capital and steadier buyback activity if the rotation persists. Losers are dividend strategies that retain sizeable growth-tech exposure (VYM/DGRO) because they carry both valuation re-rating and higher beta in a stop-start environment. Supply-chain impacts are minimal, but expect corporate behavior to shift subtly: firms with stable cash returns and visible buybacks will be prioritized for index inclusion and engagement, pressuring lower-yielding growth firms to step up buybacks or dividends to maintain index footprint.

Key risks and catalysts: a renewed AI momentum or a surprise dovish Fed that rekindles growth multiple expansion can reverse flows within weeks; conversely, a sustained commodity shock or a couple of CPI prints above consensus could extend SCHD’s leadership for months. Watch quarterly buyback announcements and dividend guidance from top 20 constituents, OI/volume in SCHD options (a proxy for retail participation), and flows into growth beta ETFs — these are the highest-probability near-term triggers. Time horizons: expect trading opportunities over 1–6 months, but position for compounding effects over 12–36 months if dividends continue to be preferentially priced.

Key Decisions for Investors

• Initiate a tactical overweight in SCHD (3% of NAV) sized to be a defensive core position; scale in on 3–6% pullbacks. Target 8–12% total return in 6–12 months driven by yield re-rate and energy cash-flow tailwinds; set a tactical stop at -8% absolute or re-evaluate if QQQ outperforms by 10% in 30 days (tech-led regime change).
• Pair trade: go long SCHD and short QQQ on a beta-neutral basis (size short QQQ to offset ~0.6 equity beta of SCHD) for a 3–6 month trade expressing dividend rotation. Expect 5–8% relative outperformance if rotation continues; cap loss at 10–12% if broad-market tech leadership reasserts within the window.
• Covered-call overlay: sell 45–60 day calls ~3%–5% OTM on existing SCHD exposure to harvest incremental yield (~2–3% annualized); roll or close if implied vol drops >25% or if SCHD rallies past the strike (accept assignment). This boosts carry in a sideways-to-up market and protects modestly on downside through premium income.
• Relative-arb vs VYM: go long SCHD / short VYM (equal-dollar) for 6–12 months to capture higher dividend elasticity and lower tech beta. Target 6–10% relative return; cut position if VYM narrows spread in dividend growth metrics or if macro shifts favor growth multiples (e.g., consistent disinflation data for 2+ months).